Evidence Report: The efficacy and safety of mitoxantrone (Novantrone) in the treatment of multiple sclerosis: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology [Image: see text]

OBJECTIVE: The chemotherapeutic agent mitoxantrone was approved for use in multiple sclerosis (MS) in 2000. After a review of all the available evidence, the original report of the Therapeutics and Technology Assessment Subcommittee in 2003 concluded that mitoxantrone probably reduced clinical attac...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Marriott, James J., Miyasaki, Janis M., Gronseth, Gary, O'Connor, Paul W.
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Academy of Neurology 2010
Schlagworte:
Special Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2871006/
https://ncbi.nlm.nih.gov/pubmed/20439849
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0b013e3181dc1ae0
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge